BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31397964)

  • 1. Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes.
    Lentine KL; Shah KS; Kobashigawa JA; Xiao H; Zhang Z; Axelrod DA; Lam NN; Segev DL; McAdams-DeMarco MA; Randall H; Hess GP; Yuan H; Vest LS; Kasiske BL; Schnitzler MA
    Am J Transplant; 2019 Dec; 19(12):3405-3414. PubMed ID: 31397964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.
    Lentine KL; Lam NN; Naik AS; Axelrod DA; Zhang Z; Dharnidharka VR; Hess GP; Segev DL; Ouseph R; Randall H; Alhamad T; Devraj R; Gadi R; Kasiske BL; Brennan DC; Schnitzler MA
    Am J Transplant; 2018 Dec; 18(12):2987-2999. PubMed ID: 29498196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records.
    Lentine KL; Salvalaggio PR; Caliskan Y; Lam NN; McAdams-DeMarco M; Axelrod D; Segev DL; Myaskovsky L; Dew MA; Bruschwein H; Levine DJ; Sweet S; Hess GP; Kasiske BL; Schnitzler MA
    J Heart Lung Transplant; 2021 Jun; 40(6):513-524. PubMed ID: 33846078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data.
    Lentine KL; Yuan H; Tuttle-Newhall JE; Xiao H; Chawa V; Axelrod D; Brennan DC; Dharnidharka VR; Beuer C; Schnitzler MA
    Transplantation; 2015 Jan; 99(1):187-96. PubMed ID: 25531895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival implications of opioid use before and after liver transplantation.
    Randall HB; Alhamad T; Schnitzler MA; Zhang Z; Ford-Glanton S; Axelrod DA; Segev DL; Kasiske BL; Hess GP; Yuan H; Ouseph R; Lentine KL
    Liver Transpl; 2017 Mar; 23(3):305-314. PubMed ID: 28027603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Scientific Registry of Transplant Recipients posttransplant program-specific outcome ratings at listing with subsequent recipient outcomes after transplant.
    Wey A; Salkowski N; Kasiske BL; Skeans M; Schaffhausen CR; Gustafson SK; Israni AK; Snyder JJ
    Am J Transplant; 2019 Feb; 19(2):391-398. PubMed ID: 30053337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data.
    Vest LS; Koraishy FM; Zhang Z; Lam NN; Schnitzler MA; Dharnidharka VR; Axelrod D; Naik AS; Alhamad TA; Kasiske BL; Hess GP; Lentine KL
    Clin Transplant; 2018 Aug; 32(8):e13302. PubMed ID: 29851159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome implications of benzodiazepine and opioid co-prescription in kidney transplant recipients.
    Lam NN; Schnitzler MA; Axelrod DA; Xiao H; McAdams-DeMarco M; Segev DL; Massie AB; Dharnidharka VR; Naik AS; Muzaale AD; Hess GP; Kasiske BL; Lentine KL
    Clin Transplant; 2020 Sep; 34(9):e14005. PubMed ID: 32510628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant Opioid Use and Survival After Lung Transplantation.
    Vahidy S; Li D; Hirji A; Kapasi A; Weinkauf J; Laing B; Lien D; Halloran K
    Transplantation; 2020 Aug; 104(8):1720-1725. PubMed ID: 32732852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pretransplant and posttransplant program ratings with candidate mortality after listing.
    Wey A; Gustafson SK; Salkowski N; Kasiske BL; Skeans M; Schaffhausen CR; Israni AK; Snyder JJ
    Am J Transplant; 2019 Feb; 19(2):399-406. PubMed ID: 30040191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pre-heart transplant body mass index on posttransplant outcomes: An analysis of the ISHLT Registry Data.
    Doumouras BS; Fan CS; Mueller B; Dipchand AI; Manlhiot C; Stehlik J; Ross HJ; Alba AC
    Clin Transplant; 2019 Jul; 33(7):e13621. PubMed ID: 31152559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant.
    Wise B; Wilson LZ; Taber DJ; Pilch NA; Rohan V; Fleming JN
    Pharmacotherapy; 2021 Jan; 41(1):6-13. PubMed ID: 33107627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients.
    Abbott KC; Fwu CW; Eggers PW; Eggers AW; Kline PP; Kimmel PL
    Transplantation; 2018 Jun; 102(6):994-1004. PubMed ID: 29319627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation.
    Lentine KL; Lam NN; Xiao H; Tuttle-Newhall JE; Axelrod D; Brennan DC; Dharnidharka VR; Yuan H; Nazzal M; Zheng J; Schnitzler MA
    Am J Nephrol; 2015; 41(2):165-76. PubMed ID: 25832723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.
    Lentine KL; Lam NN; Schnitzler MA; Hess GP; Kasiske BL; Xiao H; Axelrod D; Garg AX; Schold JD; Randall H; Dzebisashvili N; Brennan DC; Segev DL
    Am J Transplant; 2017 Mar; 17(3):744-753. PubMed ID: 27589826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation.
    Cron DC; Tincopa MA; Lee JS; Waljee AK; Hammoud A; Brummett CM; Waljee JF; Englesbe MJ; Sonnenday CJ
    Transplantation; 2021 Jan; 105(1):100-107. PubMed ID: 32022738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant malignancy as a risk factor for posttransplant malignancy after heart transplantation.
    Yoosabai A; Mehta A; Kang W; Chaiwatcharayut W; Sampaio M; Huang E; Bunnapradist S
    Transplantation; 2015 Feb; 99(2):345-50. PubMed ID: 25606783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.
    Lentine KL; Naik AS; Ouseph R; Zhang Z; Axelrod DA; Segev DL; Dharnidharka VR; Brennan DC; Randall H; Gadi R; Lam NN; Hess GP; Kasiske BL; Schnitzler MA
    Transpl Int; 2018 Jan; 31(1):20-31. PubMed ID: 28771882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic opioid use following anterior cervical discectomy and fusion surgery for degenerative cervical pathology.
    Harris AB; Marrache M; Jami M; Raad M; Puvanesarajah V; Hassanzadeh H; Lee SH; Skolasky R; Bicket M; Jain A
    Spine J; 2020 Jan; 20(1):78-86. PubMed ID: 31536805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.